Skip to content
Guess what? Valuesider just got better: smarter and more intuitive.
AstraZeneca PLC

AZN-OLD

AstraZeneca PLC

AstraZeneca PLC historical holders

total: 6

Chou Associates Management AstraZeneca PLC transactions over time

Total transactions:
3
New positions:
1
Sold out:
1
Reduced:
1
Held since:
2013 Q4
Held for:
13 quarters
Latest activity:
2017 Q1
Francis Chou has been an institutional investor in AstraZeneca PLC (AZN-OLD) since 2013 Q4. According to 2026 Q1 report, Francis Chou doesn't hold any shares. The fund/company first acquired AZN-OLD in 2013 Q4, initially purchasing 26,000 shares. Since the initial investment, Chou Associates Management has made 2 more transactions in this position.

When did Francis Chou exit their AZN-OLD position?

Francis Chou no longer holds AstraZeneca PLC (AZN-OLD). They sold off their entire position in 2017 Q1, closing out an investment that began in 2013 Q4.

When did Francis Chou first invest in AZN-OLD?

Francis Chou first invested in AstraZeneca PLC (AZN-OLD) in 2013 Q4 at the reported quarter-end price of $29.46 per share, acquiring 26,000 shares in their initial purchase.

What is Francis Chou's average cost basis for AZN-OLD?

Based on historical transaction data, Francis Chou's estimated cost basis for AstraZeneca PLC (AZN-OLD) is approximately $29.46 per share. This represents their average reported price* across all buy transactions.

Estimated cost basis*

Weighted AVG buy price:
$29.46
Weighted AVG sell price:
$58.96

AZN-OLD transactions history by Chou Associates Management

3 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2017 Q1
0.00%
$54.69
-100% (-13,000)
2015 Q3
0.28%
$63.23
-50.00% (-13,000)
2013 Q4
0.22%
$29.46
new
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.